Metformin use and cardiovascular outcomes in patients with diabetes and chronic kidney disease: a nationwide cohort study

Min-Ho KIM; Hyung-Jung OH; Soon-Hyo KWON; Jin-Seok JEON; Hyunjin NOH; Dong-Cheol HAN; Hyoungnae KIM; Dong-Ryeol RYU.
Kidney Research and Clinical Practice ; : 660-672, 2021.
Artículo en Inglés | WPRIM | ID: wpr-917034

Documentos relacionados

  1. Metformin use and cardiovascular outcomes in patients with diabetes and chronic kidney disease: a nationwide cohort study.
  2. [Intrajejunal levodopa in Parkinson's disease: Optimization of PEG application].
  3. Association between serum chloride levels with mortality in incident peritoneal dialysis patients.
  4. Prognostic significance of pre-end-stage renal disease serum alkaline phosphatase for post-end-stage renal disease mortality in late-stage chronic kidney disease patients transitioning to dialysis.
  5. Association of the frequency of pre-end-stage renal disease medical care with post-end-stage renal disease mortality and hospitalization.
  6. Clinical risk implications of the CKD Epidemiology Collaboration (CKD-EPI) equation compared with the Modification of Diet in Renal Disease (MDRD) Study equation for estimated GFR.
  7. Association of Intraindividual Difference in Estimated Glomerular Filtration Rate by Creatinine vs Cystatin C and End-stage Kidney Disease and Mortality.
  8. Adverse outcomes of proton pump inhibitors in patients with chronic kidney disease: The CKD-REIN cohort study.
  9. [Non-Classical Clinical Types and Pathological Changes of Diabetic Kidney Disease: A Review].
  10. Comparison of survival rates between incident hemodialysis patients and peritoneal dialysis patients: a 5-year prospective cohort study with propensity score matching.